JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$1.09B |
| 2 |
Broadcom
AVGO
|
+$1.03B |
| 3 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$970M |
| 4 |
Vanguard Short-Term Bond ETF
BSV
|
+$877M |
| 5 |
Verizon
VZ
|
+$875M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.58B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.37B |
| 3 |
TWX
Time Warner Inc
TWX
|
+$764M |
| 4 |
IBM
IBM
|
+$737M |
| 5 |
Philip Morris
PM
|
+$640M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.15% |
| 2 | Financials | 14% |
| 3 | Technology | 12.71% |
| 4 | Healthcare | 9.7% |
| 5 | Consumer Discretionary | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2826
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.21B
| $3.61M | ﹤0.01% |
136,120
-55,175
| -29% | -$1.5M |
2013 Q2
20 quarters
|
|
|
CBLK
2827
DELISTED
Carbon Black, Inc. Common Stock
CBLK
| $3.61M | ﹤0.01% |
+138,808
| New | +$3.58M |
2018 Q2
0 quarters
|
|
|
BRS
2828
DELISTED
Bristow Group, Inc.
BRS
| $3.61M | ﹤0.01% |
255,791
-357,901
| -58% | -$5.34M |
2013 Q2
20 quarters
|
|
2829
iShares Core S&P US Value ETF
IUSV
$27.2B
| $3.61M | ﹤0.01% |
67,196
+22,012
| +49% | +$1.19M |
2016 Q1
9 quarters
|
|
|
HOLI
2830
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
| $3.6M | ﹤0.01% |
162,537
+65,221
| +67% | +$1.53M |
2017 Q4
2 quarters
|
|
2831
Oppenheimer Holdings
OPY
$1.29B
| $3.58M | ﹤0.01% |
127,768
-14,189
| -10% | -$395K |
2013 Q2
20 quarters
|
|
2832
Fidelity National Financial
FNF
$10.5B
| $3.57M | ﹤0.01% |
98,880
-593,871
| -86% | -$21.6M |
2013 Q2
20 quarters
|
|
2833
ProShares Investment Grade-Interest Rate Hedged
IGHG
$378M
| $3.57M | ﹤0.01% |
48,359
+1,194
| +3% | +$90.1K |
2017 Q1
5 quarters
|
|
2834
EverQuote
EVER
$687M
| $3.55M | ﹤0.01% |
+195,936
| New | +$3.54M |
2018 Q2
0 quarters
|
|
2835
Amphastar Pharmaceuticals
AMPH
$1.08B
| $3.54M | ﹤0.01% |
231,823
-63,901
| -22% | -$1.12M |
2014 Q3
15 quarters
|
|
|
CCEC
2836
Capital Clean Energy Carriers
CCEC
$1.26B
| $3.53M | ﹤0.01% |
164,656
+10,375
| +7% | +$227K |
2015 Q1
13 quarters
|
|
|
AKRX
2837
CALL
DELISTED
Akorn Inc
AKRX
| $3.52M | ﹤0.01% |
212,400
+191,400
| +911% | +$2.94M |
2018 Q1
1 quarter
|
|
|
FBRX
2838
DELISTED
Forte Biosciences
FBRX
| $3.52M | ﹤0.01% |
1,005
-513
| -34% | -$1.88M |
2017 Q2
4 quarters
|
|
|
GSV
2839
DELISTED
Gold Standard Ventures Corp.
GSV
| $3.52M | ﹤0.01% |
2,577,979
+28,539
| +1% | +$43.6K |
2018 Q1
1 quarter
|
|
|
BPL
2840
PUT
DELISTED
Buckeye Partners, L.P.
BPL
| $3.52M | ﹤0.01% |
+100,000
| New | +$3.82M |
2018 Q2
0 quarters
|
|
2841
Forward Air
FWRD
$537M
| $3.51M | ﹤0.01% |
59,479
+16,273
| +38% | +$932K |
2013 Q2
20 quarters
|
|
|
MGP
2842
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $3.5M | ﹤0.01% |
114,965
-976,421
| -89% | -$28.2M |
2016 Q2
8 quarters
|
|
2843
Range Resources
RRC
$8.93B
| $3.5M | ﹤0.01% |
208,911
-109,902
| -34% | -$1.66M |
2013 Q2
20 quarters
|
|
2844
Zumiez
ZUMZ
$204M
| $3.49M | ﹤0.01% |
139,493
+21,263
| +18% | +$529K |
2016 Q4
6 quarters
|
|
2845
PUT
J.M. Smucker
SJM
$12.5B
| $3.49M | ﹤0.01% |
+32,500
| New | +$3.65M |
2018 Q2
0 quarters
|
|
|
RDUS
2846
DELISTED
Radius Health, Inc.
RDUS
| $3.48M | ﹤0.01% |
118,277
+8,051
| +7% | +$254K |
2014 Q2
16 quarters
|
|
2847
Kennametal
KMT
$2.49B
| $3.48M | ﹤0.01% |
96,918
-223,015
| -70% | -$8.57M |
2013 Q2
20 quarters
|
|
2848
CALL
Enanta Pharmaceuticals
ENTA
$377M
| $3.48M | ﹤0.01% |
+30,000
| New | +$2.99M |
2018 Q2
0 quarters
|
|
|
2849
PUT
Enanta Pharmaceuticals
ENTA
$377M
| $3.48M | ﹤0.01% |
+30,000
| New | +$2.99M |
2018 Q2
0 quarters
|
|
2850
iShares US Home Construction ETF
ITB
$2.34B
| $3.47M | ﹤0.01% |
90,864
+32,698
| +56% | +$1.27M |
2013 Q2
20 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2018 Portfolio in Review
As of Q2 2018, JP Morgan Chase held 5,918 positions worth $486B, up 4.2% from $467B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2018 filing shows 539 new, 2,430 increased, 2,080 reduced and 346 closed positions. Its largest new stake was Evergy: 3,598,208 shares worth $202M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.58B.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, up from 23% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q2 2018 buy was Evergy: 3,598,208 shares worth $202M.
- JP Morgan Chase added most to Salesforce in Q2 2018, an estimated $1.09B increase.
- JP Morgan Chase's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.58B.
- JP Morgan Chase fully exited Time Warner Inc in Q2 2018, selling an estimated $764M.
- JP Morgan Chase's ten largest holdings make up 17% of its $486B portfolio in Q2 2018.
- JP Morgan Chase opened 539 new positions and closed 346 in Q2 2018.
- JP Morgan Chase's portfolio value rose 4.2% quarter-over-quarter to $486B.
Based on JP Morgan Chase's 13F filing for Q2 2018, filed 14 Aug 2018.